Drawing for THYBETAXOR

USPTO serial 79409214

THYBETAXOR

Reviewed by CopyMark Law Group

Reg. 8054740Status 700Registered
Filing date
Status date
Registration date
Dec 9, 2025
Examiner
MESSICK, TABITHA LEE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with THYBETAXOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eric Lamb

Eric Lamb Frost Brown Todd LLP111 Monument Circle, Suite 4500Indianapolis, IN 46204United States

Goods and services

ClassDescriptionStatusFirst use
005Medicines for human purposes for the treatment of inflammatory, metabolic, and immune system related diseases and disorders; diagnostic preparations for medical purposes; drugs for medical purposes, namely, pharmaceutical drug preparations for the prevention and treatment of inflammatory, metabolic, and immune system related diseases and disorders; bacteriological preparations for medical and veterinary use; biological tissue cultures for medical purposes; surgical implants comprised of living tissues; chemical preparations for medical purposes, being pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the immune system, digestive system, and metabolic system; opotherapy preparations; biological preparations for medical purposes, being pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the immune system, digestive system, and metabolic system; medicine cases, portable, filled in the nature of containers for medical use sold filled with a platelet additive solution; stem cells for medical purposes; chemical reagents for medical or veterinary purposes;ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 9, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 25, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 21, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 21, 2026FIMPFINAL DISPOSITION PROCESSED—
Apr 30, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 13, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 13, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 9, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 9, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 9, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 21, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 21, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 15, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 19, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 22, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 22, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 22, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 25, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 25, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 25, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 25, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 27, 2025RFNTREFUSAL PROCESSED BY IB—
Jun 9, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 9, 2025RFRRREFUSAL PROCESSED BY MPU—
Apr 6, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 5, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2025DOCKASSIGNED TO EXAMINER—
Nov 15, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 15, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 14, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance